Search Results - "Van Ness, B." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

by Fonseca, R, Bergsagel, P L, Drach, J, Shaughnessy, J, Gutierrez, N, Stewart, A K, Morgan, G, Van Ness, B, Chesi, M, Minvielle, S, Neri, A, Barlogie, B, Kuehl, W M, Liebisch, P, Davies, F, Chen-Kiang, S, Durie, B G M, Carrasco, R, Sezer, Orhan, Reiman, Tony, Pilarski, Linda, Avet-Loiseau, H
Published in Leukemia (01.12.2009)

Get full text

Journal Article

Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors

Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors

by Mitra, A K, Mukherjee, U K, Harding, T, Jang, J S, Stessman, H, Li, Y, Abyzov, A, Jen, J, Kumar, S, Rajkumar, V, Van Ness, B
Published in Leukemia (01.05.2016)

Get full text

Journal Article

Clinical and biological significance of RAS mutations in multiple myeloma

Clinical and biological significance of RAS mutations in multiple myeloma

by Chng, W J, Gonzalez-Paz, N, Price-Troska, T, Jacobus, S, Rajkumar, S V, Oken, M M, Kyle, R A, Henderson, K J, Van Wier, S, Greipp, P, Van Ness, B, Fonseca, R
Published in Leukemia (01.12.2008)

Get full text

Journal Article

Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib

Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib

by Stessman, H A F, Mansoor, A, Zhan, F, Janz, S, Linden, M A, Baughn, L B, Van Ness, B
Published in Leukemia (01.10.2013)

Get full text

Journal Article

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma

by Mitra, A K, Harding, T, Mukherjee, U K, Jang, J S, Li, Y, HongZheng, R, Jen, J, Sonneveld, P, Kumar, S, Kuehl, W M, Rajkumar, V, Van Ness, B
Published in Blood cancer journal (New York) (30.06.2017)

Get full text

Journal Article

High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma

High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma

by Stessman, H A F, Lulla, A, Xia, T, Mitra, A, Harding, T, Mansoor, A, Myers, C L, Van Ness, B G, Dolloff, N G
Published in Leukemia (01.11.2014)

Get full text

Journal Article

Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy

Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy

by FONSECA, R, OKEN, M. M, HARRINGTON, D, BAILEY, R. J, VAN WIER, S. A, HENDERSON, K. J, KAY, N. E, VAN NESS, B, GREIPP, P. R, DEWALD, G. W
Published in Leukemia (01.06.2001)

Get full text

Journal Article

Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells

Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells

by CHEUNG, W-C, VAN NESS, B
Published in Leukemia (01.06.2002)

Get full text

Journal Article

Clinical significance of TP53 mutation in myeloma

Clinical significance of TP53 mutation in myeloma

by Chng, W J, Price-Troska, T, Gonzalez-Paz, N, Van Wier, S, Jacobus, S, Blood, E, Henderson, K, Oken, M, Van Ness, B, Greipp, P, Rajkumar, S V, Fonseca, R
Published in Leukemia (01.03.2007)

Get full text

Journal Article

Genetic polymorphisms of EPHX1, Gsk3β, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma

Genetic polymorphisms of EPHX1, Gsk3β, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma

by Durie, B G M, Van Ness, B, Ramos, C, Stephens, O, Haznadar, M, Hoering, A, Haessler, J, Katz, M S, Mundy, G R, Kyle, R A, Morgan, G J, Crowley, J, Barlogie, B, Shaughnessy, J
Published in Leukemia (01.10.2009)

Get full text

Journal Article

The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro

The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro

by CHEUNG, W-C, VAN NESS, B
Published in Leukemia (01.02.2001)

Get full text

Conference Proceeding Journal Article

Interferon-α protects myeloma cell lines from dexamethasone-induced apoptosis

Interferon-α protects myeloma cell lines from dexamethasone-induced apoptosis

by LIU, P, OKEN, M, VAN NESS, B
Published in Leukemia (01.03.1999)

Get full text

Journal Article

The structure of ownership and corporate acquisition strategies

The structure of ownership and corporate acquisition strategies

by Wright, Peter, Kroll, Mark, Lado, Augustine, Van Ness, Bonnie
Published in Strategic management journal (01.01.2002)

Get full text

Journal Article

Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement

Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement

by BILLADEAU, D, PROSPER, F, VERFAILLIE, C, WEISDORF, D, VAN NESS, B
Published in Leukemia (01.09.1997)

Get full text

Journal Article

Is Flow Cytometric DNA Content Hypodiploidy Prognostic in Multiple Myeloma?

Is Flow Cytometric DNA Content Hypodiploidy Prognostic in Multiple Myeloma?

by Greipp, P. R., Trendle, M. C., Leong, T., Oken, M. M., Kay, N. E., Ness, B. Van, Kyle, R. A.
Published in Leukemia & lymphoma (1999)

Get full text

Journal Article

Glucose-dependent regulation of glucose transport activity, protein, and mRNA in primary cultures of rat brain glial cells

Glucose-dependent regulation of glucose transport activity, protein, and mRNA in primary cultures of rat brain glial cells

by Walker, P S, Donovan, J A, Van Ness, B G, Fellows, R E, Pessin, J E
Published in The Journal of biological chemistry (25.10.1988)

Get full text

Journal Article

$Prognostic significance of the S‐phase fraction of light‐chain‐restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on eastern cooperative oncology group treatment trial E9486$

Prognostic significance of the S‐phase fraction of light‐chain‐restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on eastern cooperative oncology group treatment trial E9486

by Trendle, M.C., Leong, T., Kyle, R.A., Katzmann, J.A., Oken, M.M., Kay, N.E., Van Ness, B.G., Greipp, P.R.
Published in American journal of hematology (01.08.1999)

Get full text

Journal Article

Initiation and processing of two kappa immunoglobulin germ line transcripts in mouse B cells

Initiation and processing of two kappa immunoglobulin germ line transcripts in mouse B cells

by MARTIN, D. J, VAN NESS, B. G
Published in Molecular and Cellular Biology (01.05.1990)

Get full text

Journal Article

Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan

Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan

by Rowley, Matt, Liu, Pocheng, Van Ness, Brian
Published in Blood (01.11.2000)

Get full text

Journal Article

Activating mutations of N- and K-ras in multiple myeloma show different clinical associations : Analysis of the Eastern cooperative oncology group phase III trial

Activating mutations of N- and K-ras in multiple myeloma show different clinical associations : Analysis of the Eastern cooperative oncology group phase III trial

by LIU, P, LEONG, T, QUAM, L, BILLADEAU, D, KAY, N. E, GREIPP, P, KYLE, R. A, OKEN, M. M, VAN NESS, B
Published in Blood (01.10.1996)

Get full text

Journal Article

1
2
3
4
5
6
7
8
Next
[8]